Tranche Update on T&L Co., Ltd.'s Equity Buyback Plan announced on June 15, 2022.
June 13, 2023 at 09:45 am
Share
From June 15, 2022 to June 30, 2022, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for KRW 0 million under the buyback announced on June 15, 2022.
T&L Co Ltd is a Korea-based company engaged in the manufacture and sale of wound treatment materials. The Company's main products include wound treatment materials, orthopedic fixing materials, structural adhesives, and water repellents. The wound treatment materials include products such as hydrocolloids, foams, and hydrogels as wetting dressing agents necessary for wound healing. The orthopedic fixture materials include medical devices used for the treatment and correction of fractures such as casts and splints. The company sells its products in domestic and overseas markets such as the United States, Germany, China, and Dubai.